At $146 per share and a $329 billion market cap, Palantir trades at 73x trailing price-to-sales, 218x trailing earnings, and an EV/EBITDA of 223x. These are not rounding errors. This is a stock priced for an outcome several multiples larger than the current business.
To justify the current valuation using a free cash flow framework, you need Palantir to compound SBC-adjusted FCF at approximately 30% annually for ten years, then apply a terminal multiple of 30x. On those assumptions, working backward from a required discount rate of 10%, the current price is defensible but not comfortable. Change the revenue growth assumption to 25% or the terminal multiple to 20x, and the stock is materially overvalued.
The analyst community reflects this uncertainty. Fifteen analysts rate PLTR a hold. Four rate it a strong sell. Only four rate it a strong buy or buy. The consensus price target is $186.60, implying roughly 27% upside from current levels, but the distribution of that consensus is wide, and the strong sell camp is credible rather than reflexively bearish.
The sentiment trend offers a different angle. Normalized sentiment scores fell from above 0.90 in mid-March to 0.33 to 0.48 in early March, coinciding with the broader technology selloff and concerns about government spending cuts. Sentiment recovered sharply by late March, back above 0.90. The underlying financials did not change during this period. What changed was macro sentiment. That volatility is inherent in a stock where the valuation leaves no margin for error on the narrative.